We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Product
Advertisement

ELEVECTA™ Producer Cell Line: For Stable, Inducible Adeno-Associated Virus Production

ELEVECTA™ Producer Cell Line: For Stable, Inducible Adeno-Associated Virus Production
Credit: Cytiva


ELEVECTA™ producer cell line is a stable line for inducible AAV production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s genome, and it requires only a single induction step to initiate AAV production.


ELEVECTA producer cell line key benefits:

  • Simplified manufacturing process: Replace multi-step transfection with single-step production by adding an induction reagent.
  • Scalability: Scale up seamlessly to achieve large quantities of AAV material.
  • Reproducibility: Benefit from a monoclonal cell line from which AAV is produced in an identical manner, enabling consistency from batch to batch.
  • Reduced COGS: Skip the need for transfection reagent and any plasmid DNA, which are the most expensive raw materials in classical AAV transient transfection.

Product Specifications
Alpha cell line HEK293 or cell line derived from human amniocytes cells (Cytiva CAP cell line )
AAV serotypes Common or engineered
Packaging capacity ~ 4.7 kb
Cell banking Non-GMP research cell bank (RCB)
Upstream process development Small scale to large scale from FastTrak™ services (optional)
Stability testing Included
About Cytiva
Cytiva is a global life sciences leader dedicated to helping customers discover and commercialize the next generation of therapeutics. Together, we bring dedicated technical expertise and a broad portfolio of tools and technologies that enable the development, manufacture, and delivery of transformative medicines to patients.
Interested in seeing more content from Cytiva?
Discover all their latest news, webinars, products and more by clicking the link below.